Open Access

ARTICLE

Tolerance and Efficacy of Regorafenib according to UGT Pharmacogenetical Status in the Treatment of Metastatic Refractory Colorectal Cancer

Pierre-Guillaume Poureau^1,2,*, Estelle Dhamelincourt², Jessica Nguyen², Hélène Babey², Emmanuelle Renaud², Margaux Geier², Michèle Boisdron-Celle³, Jean-Philippe Metges²

1 HIA Brest, Rue Colonel Fonferrier, Gastroentérologie, Brest, 29200, France
2 CHU Morvan, 2 Av Foch, Oncologie Digestive, Brest, 29200, France
3 ICO Paul Papin, Pharmacologie Toxicologie Pharmacogénétique, 15 Rue André Bocquel, Angers, 49055, France

* Corresponding Author: Pierre-Guillaume Poureau. Email: